纽约一线医生Dr. Griffin新冠更新（April 16, 2022）

 

其中，有最新的疫情信息、治疗方法及专业处理思路，愿上海等地的朋友能有所借鉴。

文末所列，都是专业引文，供感兴趣的朋友参考。

祝平安。

每周播报：https://www.microbe.tv/twiv/

-------------------------------------------------------

In COVID-19 clinical update #110, Dr. Griffin covers hospital admissions during variant outbreaks, viral load in vaccinated and unvaccinated individuals, predictive capacity of symptoms in children, comparison of antigen tests, incidence of myocarditis after vaccination, steroids during replication phase, Paxlovid efficacy and safety, fluvoxamine, sabizabutin, colchicine, and prevalence of infection in Africa.

 

Links for this episode

• Hospital admissions during Omicron and Delta variant outbreaks (Lancet)
• Viral load in unvaccinated and vaccinated individuals (Nat Med)
• Predictive Capability of symptoms in children (Clin Inf Dis)
• Comparison of antigen tests (medRxiv)
• Incidence of Myocarditis after COVID19 and non-COVID19 vaccination (Lancet)
• Steroids during viral replication phase (Resp)
• Paxlovid efficacy and safety (Pfizer)
• Fluvoxamine & Outpatient Management (JAMA)
• Sabizabutin efficacy and safety (Veru)
• Colchicine and lack of benefit (Lancet)
• SARS-CoV-2 prevalence in Africa (medRxiv)
• Contribute to ASTMH fundraiser at PWB
• Dr. Griffin’s treatment guide (pdf)
• Letters read on TWiV 889 33:35
• Timestamps by Jolene. Thanks!

Intro music is by Ronald Jenkees

Send your questions for Dr. Griffin to [e-mail]